HOME >> BIOLOGY >> NEWS
Yale technology spins out varicose vein device company: Vascular Insights, LLC

New Haven, Conn. -- A new company, Vascular Insights, LLC, was founded to develop, manufacture and market devices to treat varicose vein disease, based on technology invented by Michael Tal, M.D., assistant professor of diagnostic radiology and director of research interventional radiology at Yale University School of Medicine.

"While varicose vein disease is normally not a life threatening condition, it can cause severe leg discomfort and serious complications, including clotting, leg edema, skin ulceration and thrombophlebitis," said Tal. "However, a universal problem caused by the condition is unsightliness of the bulging veins."

Vascular Insights is developing a simplified procedure using a single, disposable product for elimination of varicose veins. Among the procedure's advantages, the company believes it will eliminate the need for anesthesia, hospitalization or surgery, and cause less damage to surrounding tissue and nerves. This would translate into considerably reduced convalescence, complications and pain for patients. Varicose veins, including sapheno-femoral reflux disease, affect between 75 and 150 million people in North America and Western Europe. The condition involves major blood vessels of the leg, and is different than "spider veins," which affects the minor blood vessels.

Traditional therapy for varicose veins is surgery, but worldwide only an estimated one million people undergo the extensive surgical stripping and ligation operations each year at a cost of as much as between $2,500 and $5,000 per leg.

"The simplicity of the Vascular Insights approach represents an attractive new treatment option for the present one million annual procedures and the 30 to 50 million varicose vein sufferers in the US who currently do not seek treatment," said John Marano,
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
5-Apr-2006


Page: 1 2

Related biology news :

1. AFCYBER holds science and technology symposium
2. New technology reveals seal behavior
3. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
4. FDA Nanotechnology Task Force takes positive step forward
5. Liverpool amongst first in UK to install unique DNA sequencing technology
6. EPA foregoes opportunity to improve nanotechnology oversight
7. The Cancer Genome Atlas awards funds for technology development
8. Autism theory put to the test with new technology
9. Nanotechnology, medicine and bioethics
10. Nanotechnology: consumers must be convinced benefits outweigh risks
11. Stem cell licensing deal positions Toronto as world leader in technology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: